Alamar Biosciences, Inc. ALMR
Set alert
29.51 USD +0.57 +1.97%
As of Nov 3, 1:00 PM ET
29.18 Day range 30.27
18.85 52-week range 39.61
- YTD
- +34.14%
- 1 year
- +34.14%
- Open
- 29.18
- Prev close
- 28.94
- Mkt cap
- 2.04B
- Vol
- 250.64K
- Avg vol
- 557.51K
- EPS
- -1.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 29.18
- High
- 30.27
- Forward P/E
- -64.05
- Beta
- 0.00
- Short ratio
- 3.53
- Inst. own
- 57.21%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 30.65
- 200-d avg
- 26.93
- 1y target
- 35.40
MAX chart
Events in this range
- May 8, 2026Earnings: -1.74; estimate -1.71; surprise -1.75%
- May 12, 2026Rating: Stifel · — → Buy
- May 12, 2026Rating: JP Morgan · — → Overweight
- May 12, 2026Rating: TD Cowen · — → Buy
- May 12, 2026Rating: Leerink Partners · — → Outperform
- Aug 10, 2026Earnings: -0.22; estimate -0.30787; surprise 28.54%
- Aug 11, 2026Rating: JP Morgan · Overweight → Overweight
- Aug 11, 2026Rating: Stifel · Buy → Buy
- Nov 3, 2026Earnings: —; estimate -0.2015; surprise —%
Signals (47)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
Newest 20 of 47.
Analyst view
Price target (mean) 35.40 +20.0% upside
Now 29.51
- Target (low)
- 31.00
- Target (mean)
- 35.40
- Target (high)
- 45.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy1
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.18688 | -0.26 – -0.10 | 0.00 | 0.0% | 30.19M | 0.0% | 4 |
| Next quarter | -0.18492 | -0.24 – -0.13 | 0.00 | 0.0% | 32.88M | 0.0% | 4 |
| Current year | -1.10 | -1.31 – -0.86 | 0.00 | 0.0% | 118.58M | 0.0% | 4 |
| Next year | -0.4518 | -0.90 – -0.12 | -1.10 | +59.0% | 165.71M | +39.8% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 11, 2026 | Stifel | Maintained | Buy | Buy |
| Aug 11, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 12, 2026 | Leerink Partners | Initiated | — | Outperform |
| May 12, 2026 | TD Cowen | Initiated | — | Buy |
| May 12, 2026 | JP Morgan | Initiated | — | Overweight |
| May 12, 2026 | Stifel | Initiated | — | Buy |
